Kathleen A. Ross

Evaluation of biocompatibility and administration site reactogenicity of polyanhydride-particle-based platform for vaccine delivery.

Structural and antigenic stability of H5N1 hemagglutinin trimer upon release from polyanhydride nanoparticles.

Lung deposition and cellular uptake behavior of pathogen-mimicking nanovaccines in the first 48 hours.

Effect of nanovaccine chemistry on humoral immune response kinetics and maturation.

Hemagglutinin-based polyanhydride nanovaccines against H5N1 influenza elicit protective virus neutralizing titers and cell-mediated immunity.

Nano-enabled delivery of diverse payloads across complex biological barriers.

Emerging trends in the immunotherapy of pancreatic cancer.

pH-Responsive Microencapsulation Systems for the Oral Delivery of Polyanhydride Nanoparticles.

Polyanhydride Nanovaccine Induces Robust Pulmonary B and T Cell Immunity and Confers Protection Against Homologous and Heterologous Influenza A Virus Infections.

Single Dose of a Polyanhydride Particle-Based Vaccine Generates Potent Antigen-Specific Antitumor Immune Responses.

Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma.

Amphiphilic polyanhydride-based recombinant MUC4β-nanovaccine activates dendritic cells.

Effective mosaic-based nanovaccines against avian influenza in poultry.

Pentaerythritol-based lipid A bolsters the antitumor efficacy of a polyanhydride particle-based cancer vaccine.

Polymeric Nanoparticle-Based Vaccine Adjuvants and Delivery Vehicles.

Prefusion F-Based Polyanhydride Nanovaccine Induces Both Humoral and Cell-Mediated Immunity Resulting in Long-Lasting Protection against Respiratory Syncytial Virus.